Optimizing Treatment Outcomes in Advanced NSCLC with Concurrent Biomarker Testing - Episode 5
Medical experts recommend that EGFR, ALK, and PD-L1 testing be performed as reflex tests for patients with early-stage non-small cell lung cancer to inform personalized treatment strategies.